Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,757 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,046)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00252798 | ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer | completed | Phase 1 | 44 | AstraZenecaINDUSTRY | 1 | Dec 19, 2007 | clinicaltrials |
| NCT00333294 | Phase II Iressa + Irradiation Followed by Chemo in NSCLC | completed | Phase 2 | 50 | AstraZenecaINDUSTRY | 1 | Dec 19, 2007 | clinicaltrials |
| NCT00252707 |
| Iressa 2nd Line Phase III Study in Japan |
| completed |
| Phase 3 |
| 484 |
| AstraZenecaINDUSTRY |
| 1 |
| Dec 18, 2007 |
| clinicaltrials |
| NCT00073151 | A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 30 | AbbottINDUSTRY | 1 | Nov 29, 2007 | clinicaltrials |
| NCT00561054 | Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC(Coimbra) | unknown | Phase 2 | 47 | Grupo Portugues de Estudo do Cancro do PulmaoOTHER | 1 | Nov 20, 2007 | clinicaltrials |
| NCT00259675 | Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC | completed | Phase 2 | 100 | University of SaskatchewanOTHER | 1 | Nov 15, 2007 | clinicaltrials |
| NCT00190710 | A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer | completed | Phase 3 | 242 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 14, 2007 | clinicaltrials |
| NCT00283478 | Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer | completed | N/A | 20 | Kentuckiana Cancer InstituteOTHER | 1 | Oct 31, 2007 | clinicaltrials |
| NCT00081315 | Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer | completed | Phase 2 | 130 | MedImmune LLCINDUSTRY | 1 | Aug 21, 2007 | clinicaltrials |
| NCT00061646 | Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 2 | 25 | AbbottINDUSTRY | 1 | Aug 14, 2007 | clinicaltrials |
| NCT00173875 | Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer | completed | Phase 2 | 108 | National Taiwan University HospitalOTHER | 1 | Jul 30, 2007 | clinicaltrials |
| NCT00490659 | Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes | completed | Phase 2 | 13 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 25, 2007 | clinicaltrials |
| NCT00489983 | Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy | completed | Phase 2 | 91 | Eli Lilly and CompanyINDUSTRY | 3 | Jun 22, 2007 | clinicaltrials |
| NCT00489996 | Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer | completed | Phase 2 | 100 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 22, 2007 | clinicaltrials |
| NCT00243204 | Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy | terminated | Phase 3 | 400 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00290017 | Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy | terminated | Phase 3 | 400 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00054795 | Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) | completed | Phase 3 | 550 | Pharmacyclics LLC.INDUSTRY | 8 | May 8, 2007 | clinicaltrials |
| NCT00066885 | Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 80 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00034827 | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer | completed | Phase 2 | 172 | PfizerINDUSTRY | 1 | May 4, 2007 | clinicaltrials |
| NCT00105092 | Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | May 1, 2007 | clinicaltrials |
| NCT00466284 | Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer | unknown | Phase 2 | 46 | Grupo Gallego de Cancer de PulmonOTHER | 1 | Apr 27, 2007 | clinicaltrials |
| NCT00464282 | Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer | completed | — | — | Gunma UniversityOTHER | 0 | Apr 23, 2007 | clinicaltrials |
| NCT00192829 | Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma | unknown | — | 100 | Rambam Health Care CampusOTHER | 1 | Apr 11, 2007 | clinicaltrials |
| NCT00425022 | VATS Lobectomy for Clinical Stage IB or II Lung Cancer | unknown | Phase 2 | 40 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 30, 2007 | clinicaltrials |
| NCT00061464 | Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190840 | A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 186 | Eli Lilly and CompanyINDUSTRY | 8 | Jan 26, 2007 | clinicaltrials |
| NCT00191230 | Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191256 | Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer | completed | Phase 2 | 77 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191490 | A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer | completed | Phase 2 | 162 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191620 | Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer. | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Jan 26, 2007 | clinicaltrials |
| NCT00260026 | Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00179686 | A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 40 | Celgene CorporationINDUSTRY | 1 | Dec 20, 2006 | clinicaltrials |
| NCT00062907 | Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer | unknown | Phase 1 | 9 | Corixa CorporationINDUSTRY | 1 | Dec 6, 2006 | clinicaltrials |
| NCT00174356 | PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients | completed | Phase 1 | 39 | PfizerINDUSTRY | 2 | Nov 8, 2006 | clinicaltrials |
| NCT00168883 | Study for Patients With Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 80 | Charite University, Berlin, GermanyOTHER | 1 | Nov 1, 2006 | clinicaltrials |
| NCT00364663 | The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Aug 16, 2006 | clinicaltrials |
| NCT00191841 | Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 24, 2006 | clinicaltrials |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 21 | Jul 19, 2006 | clinicaltrials |
| NCT00034606 | Comparing 3 Schedules of Alimta Plus Gemzar | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00042679 | A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00051493 | ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 19, 2006 | clinicaltrials |
| NCT00339586 | First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene | unknown | Phase 2 | 40 | Universitair Ziekenhuis BrusselOTHER | 1 | Jun 21, 2006 | clinicaltrials |
| NCT00285675 | Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 | unknown | Phase 2 | 25 | NovaceaINDUSTRY | 2 | May 31, 2006 | clinicaltrials |
| NCT00082472 | Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) | unknown | Phase 1 / Phase 2 | 30 | ZivenaINDUSTRY | 1 | Apr 18, 2006 | clinicaltrials |
| NCT00268684 | Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC | unknown | Phase 3 | 381 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Feb 28, 2006 | clinicaltrials |
| NCT00265694 | Random Trial for Elderly Patients With NSCLC | unknown | Phase 3 | — | Inje UniversityOTHER | 1 | Dec 15, 2005 | clinicaltrials |
| NCT00150657 | Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer | unknown | Phase 2 | 45 | St. John Providence Health SystemOTHER | 1 | Nov 29, 2005 | clinicaltrials |
| NCT00173680 | Methylation Status of CD44 Promoter Region in Primary Lung Cancer | unknown | — | 40 | National Taiwan University HospitalOTHER | 1 | Nov 24, 2005 | clinicaltrials |
| NCT00155116 | SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Nov 23, 2005 | clinicaltrials |
| NCT00254319 | Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | — | The Cooper Health SystemOTHER | 1 | Nov 16, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Dec 19, 2007source: clinicaltrials